[PERSON]
Kabir Nath
Featured in 2 tracked stories · first seen
Situations
COMPASS Pathways psilocybin therapy development
2 clusters · 5 sources · last updated
Latest: Compass Pathways prepares FDA submission for psilocybin therapy
Biotechnology company COMPASS Pathways is advancing its lead candidate, COMP360, a synthetic psilocybin formulation designed to treat treatment-resistant depression. In mid-September 2026, the company reported a Q2 finan
Also covered in
-
MAHA Summit addresses chronic disease and healthcare innovation
[HEALTH] · 2 sources ·